A new study of nearly 149,000 women with diabetes over 14 years showed an overall 18% reduced breast cancer risk for women who used low-dose aspirin compared to those who did not.
The study design and results are published in an article in Journal of Women’s Health, 玛丽安 Liebert 同行评审的出版物, 公司, 出版商.
在一篇题为 “Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan,” Yi-Sun Yang, MD, 博士学位, Chien-Ning Huang, MD, 博士学位, and coauthors from Chung Shan Medical University Hospital and Hung Kuang University, Taichung, 台湾, defined low-dose aspirin use as intake of 75-165 mg daily.
The researchers reported that a high cumulative dose of aspirin over the 14-year study period reduced breast cancer risk by 47%, whereas low and medium cumulative doses did not reduce risk.
“妇女型 2 diabetes have an increased risk of breast cancer, and these results suggest that the same low-dose aspirin that many of these women take to prevent cardiovascular disease may also help reduce their risk of breast cancer,” 说苏珊 G. Kornstein, MD, 妇女杂志总编辑 ’ s 健康, 妇女弗吉尼亚英联邦大学研究所的执行主任 ’ s 健康, 里士满, VA, 和女子学院的院长 ’ s 健康.
信用: 玛丽安 Liebert, 公司, 出版商